Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingke Pingchuan Granule for adult community-acquired pneumonia
ChiCTR2400083218Phase 4Recruiting
- Sponsor
- Jiangsu Shengze Hospital
- Start
- Apr 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of qingkepingchuan in community-acquired pneumonia (CAP) (2 arms), sponsored by Jiangsu Shengze Hospital. Primary endpoint: Clinical effective rate. Started Apr 2024; status: recruiting.
02
Drugs
qingkepingchuan
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on ChiCTR2400083218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083218.